AstraZeneca expects sales to accelerate in 2022
AstraZeneca expected to boost sales in 2022 after reporting better-than-expected fourth-quarter profit. The British-Swedish drugmaker said it made nearly $4 ...
AstraZeneca expected to boost sales in 2022 after reporting better-than-expected fourth-quarter profit. The British-Swedish drugmaker said it made nearly $4 ...